We design clinical research around patients and study participants, using digital and decentralized approaches where they reduce unnecessary travel and time burden, improve accessibility, and strengthen the trial experience. We execute every study under rigorous ethical and regulatory standards, including ICH-GCP and the Declaration of Helsinki, protecting patient rights, safety, and data integrity throughout the clinical pathway.

We build inclusive teams where people can contribute their expertise and perspectives with confidence. We maintain a safe, respectful workplace and uphold clear standards against discrimination and harassment, strengthening the environment our teams need to deliver responsible clinical research.

We reduce our environmental impact through science-based targets backed by SBTi validation. Using 2024 as our base year, we are advancing measurable reductions across Scope 1 and Scope 3 emissions while transitioning to 100% renewable electricity.

• Near-term 2030:
  • 42.0% reduction in absolute Scope 1 GHG emission
  • 100% renewable electricity
  • 51.6% reduction in Scope 3 GHG emissions per EUR of value added
    
    
• Long-term 2050:
  • 90.0% reduction in absolute Scope 1 GHG emissions
  • 97.0% reduction in Scope 3 GHG emissions per EUR of value added
  • Net-zero greenhouse gas emissions across our value chain

We extend our standards for ethical and responsible business conduct across the relationships that support our clinical work. We expect clients, suppliers, and partners to uphold clear principles on ethics, labor, human rights, and environmental responsibility, strengthening accountability across the value chain.